| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 127K | $8.03M | $62.98 | May 20, 2025 | Direct |
| Rockley Photonics Holdings Ltd | President & CFO | Restricted Stock Unit | 1.89M | Oct 21, 2022 | Direct | ||
| Rockley Photonics Holdings Ltd | President & CFO | Stock Option (right to buy) | 1.89M | Oct 21, 2022 | Direct | ||
| BIOMARIN PHARMACEUTICAL INC | Director | Stock Option (Right to Buy Common Stock) | 0 | Jun 3, 2024 | Direct | ||
| Intersect ENT, Inc. | EVP & Chief Financial Officer | Common Stock | 0 | $28.25 | May 13, 2022 | Direct | |
| Intersect ENT, Inc. | EVP & Chief Financial Officer | Stock Options (Right to buy) | 0 | $28.25 | May 13, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 20, 2025 | 1 | $0 | 4 | May 22, 2025 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Jun 3, 2024 | 3 | -$51 | 4 | Jun 4, 2024 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Jan 8, 2024 | 1 | $0 | 4 | Jan 23, 2024 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 23, 2023 | 1 | $0 | 4 | May 24, 2023 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 12, 2023 | 3 | -$63 | 4 | May 17, 2023 | Director |
| RKLY | Rockley Photonics Holdings Ltd | Oct 21, 2022 | 2 | $0 | 4 | Oct 21, 2022 | President & CFO |
| RKLY | Rockley Photonics Holdings Ltd | Oct 20, 2022 | 0 | $0 | 3 | Oct 21, 2022 | President & CFO |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| XENT | Intersect ENT, Inc. | May 13, 2022 | 5 | -$7.7M | 4 | May 16, 2022 | EVP & Chief Financial Officer |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 2, 2022 | 4 | $64.50 | 4 | May 4, 2022 | Director |
| XENT | Intersect ENT, Inc. | Feb 1, 2022 | 2 | -$63.6K | 4 | Feb 4, 2022 | EVP & Chief Financial Officer |
| XENT | Intersect ENT, Inc. | Nov 29, 2021 | 1 | -$171K | 4 | Dec 1, 2021 | EVP & Chief Financial Officer |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 6, 2021 | 3 | $105 | 4 | May 7, 2021 | Director |